Influence of non-nucleoside reverse transcriptase inhibitors (efavirenz and nevirapine) on the pharmacodynamic activity of gliclazide in animal models-Reference-Cited by-同舟云学术

Influence of non-nucleoside reverse transcriptase inhibitors (efavirenz and nevirapine) on the pharmacodynamic activity of gliclazide in animal models

Published:2009-10-09 Issue:1 Volume:1 Page:
ISSN:1758-5996
Container-title:Diabetology & Metabolic Syndrome
language:en
Short-container-title:Diabetol Metab Syndr

Author:

Mastan SK,Kumar K Eswar

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://link.springer.com/content/pdf/10.1186/1758-5996-1-15.pdf

Reference50 articles.

1. Satyanarayana S, Kilari EK: Influence of nicorandil on the pharmacodynamics and pharmacokinetics of gliclazide in rats and rabbits. Mol Cell Biochem. 2006, 291: 101-105. 10.1007/s11010-006-9202-y.

2. Saely CH, Aczel S, Marte T, Langer P, Drexel H: Cardiovascular complications in type 2 diabetes mellitus depends on the coronary angiographic state rather than on the diabetes state. Diabetologia. 2004, 47 (1): 145-146. 10.1007/s00125-003-1274-6.

3. King H, Aubert RE, Herman WH: Global burden of diabetes, 1995-2025: Prevalence, numerical estimates, and projections. Diabetes Care. 1998, 21 (9): 1414-1431. 10.2337/diacare.21.9.1414.

4. Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, Little RR, Wiedmeyer HM, Byrd-Holt DD: Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care. 1998, 21 (4): 518-524. 10.2337/diacare.21.4.518.

5. Hruz PW: Molecular mechanisms for altered glucose homeostasis in HIV infection. Am J Infect Dis. 2006, 2 (3): 187-192.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bosentan effect on Teneligliptin’s Antidiabetic effect in Animal Model;Research Journal of Pharmacy and Technology;2023-02-28

2. Drug–Drug Interactions in People Living With HIV at Risk of Hepatic and Renal Impairment: Current Status and Future Perspectives;The Journal of Clinical Pharmacology;2022-02-08

3. Influence of aprepitant on the pharmacodynamics and pharmacokinetics of gliclazide in rats and rabbits;PeerJ;2018-05-22

4. Population pharmacokinetics of gliclazide in normal and diabetic rabbits;Biopharmaceutics & Drug Disposition;2018-04-21

5. HIV antiretroviral drug Efavirenz induces anxiety-like and depression-like behavior in rats: evaluation of neurotransmitter alterations in the striatum;European Journal of Pharmacology;2017-03